1. Home
  2. ELUT vs THCH Comparison

ELUT vs THCH Comparison

Compare ELUT & THCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELUT
  • THCH
  • Stock Information
  • Founded
  • ELUT 2015
  • THCH 2018
  • Country
  • ELUT United States
  • THCH China
  • Employees
  • ELUT N/A
  • THCH N/A
  • Industry
  • ELUT Medical Specialities
  • THCH Blank Checks
  • Sector
  • ELUT Health Care
  • THCH Finance
  • Exchange
  • ELUT Nasdaq
  • THCH Nasdaq
  • Market Cap
  • ELUT 88.4M
  • THCH 84.8M
  • IPO Year
  • ELUT 2020
  • THCH N/A
  • Fundamental
  • Price
  • ELUT $2.09
  • THCH $2.47
  • Analyst Decision
  • ELUT Strong Buy
  • THCH
  • Analyst Count
  • ELUT 2
  • THCH 0
  • Target Price
  • ELUT $8.00
  • THCH N/A
  • AVG Volume (30 Days)
  • ELUT 29.0K
  • THCH 22.5K
  • Earning Date
  • ELUT 08-14-2025
  • THCH 08-26-2025
  • Dividend Yield
  • ELUT N/A
  • THCH N/A
  • EPS Growth
  • ELUT N/A
  • THCH N/A
  • EPS
  • ELUT N/A
  • THCH N/A
  • Revenue
  • ELUT $23,683,000.00
  • THCH $187,384,526.00
  • Revenue This Year
  • ELUT $20.10
  • THCH N/A
  • Revenue Next Year
  • ELUT $85.89
  • THCH N/A
  • P/E Ratio
  • ELUT N/A
  • THCH N/A
  • Revenue Growth
  • ELUT N/A
  • THCH N/A
  • 52 Week Low
  • ELUT $1.61
  • THCH $1.95
  • 52 Week High
  • ELUT $5.12
  • THCH $5.15
  • Technical
  • Relative Strength Index (RSI)
  • ELUT 52.40
  • THCH 34.92
  • Support Level
  • ELUT $1.96
  • THCH $2.47
  • Resistance Level
  • ELUT $2.30
  • THCH $2.79
  • Average True Range (ATR)
  • ELUT 0.14
  • THCH 0.24
  • MACD
  • ELUT 0.01
  • THCH -0.02
  • Stochastic Oscillator
  • ELUT 45.03
  • THCH 53.61

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About THCH TH International Limited Ordinary shares

TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under single reportable segment, Tim Hortons. The company's revenue is derived from its operations in the PRC.

Share on Social Networks: